Regis Healthcare Ltd's stock price surged 6.01% during intraday trading on Thursday, marking a significant upward movement for the healthcare company.
The sharp rise appears to be driven by the company's positive financial outlook, as it expects its FY26 underlying EBITDA to reach approximately A$135 million, which is at the top end of its guidance range.